Q2 2019 Earnings Estimate for LHC Group, Inc. (LHCG) Issued By William Blair

LHC Group, Inc. (NASDAQ:LHCG) – William Blair lifted their Q2 2019 earnings estimates for LHC Group in a research note issued on Monday, April 8th, Zacks Investment Research reports. William Blair analyst M. Larew now expects that the health services provider will earn $1.02 per share for the quarter, up from their previous forecast of $1.01. William Blair also issued estimates for LHC Group’s FY2020 earnings at $4.70 EPS.

A number of other research analysts also recently issued reports on LHCG. BidaskClub downgraded LHC Group from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 28th. Craig Hallum upped their price target on LHC Group from $93.00 to $114.00 and gave the company a “hold” rating in a report on Friday, March 1st. They noted that the move was a valuation call. SunTrust Banks upped their price target on LHC Group to $130.00 and gave the company a “buy” rating in a report on Friday, March 1st. Robert W. Baird upped their price target on LHC Group from $98.00 to $120.00 and gave the company a “neutral” rating in a report on Monday, March 4th. Finally, Barclays upped their price target on LHC Group from $95.00 to $104.00 and gave the company an “equal weight” rating in a report on Thursday, March 21st. One analyst has rated the stock with a sell rating, four have issued a hold rating and ten have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $113.25.

Shares of NASDAQ:LHCG traded up $2.44 during midday trading on Thursday, reaching $114.82. 214,286 shares of the company’s stock traded hands, compared to its average volume of 296,945. The company has a market cap of $3.62 billion, a P/E ratio of 32.34, a PEG ratio of 2.00 and a beta of 0.87. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.78 and a quick ratio of 1.78. LHC Group has a one year low of $69.89 and a one year high of $115.54.

LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, February 27th. The health services provider reported $1.03 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.03. LHC Group had a return on equity of 8.40% and a net margin of 3.50%. The business had revenue of $509.80 million for the quarter, compared to the consensus estimate of $522.21 million. During the same period in the previous year, the company posted $0.62 earnings per share. The company’s revenue for the quarter was up 75.1% compared to the same quarter last year.

Hedge funds have recently bought and sold shares of the business. Parallel Advisors LLC increased its position in LHC Group by 790.0% in the first quarter. Parallel Advisors LLC now owns 267 shares of the health services provider’s stock worth $30,000 after buying an additional 237 shares in the last quarter. Sageworth Trust Co purchased a new stake in LHC Group in the first quarter worth about $36,000. Financial Gravity Companies Inc. purchased a new stake in LHC Group in the fourth quarter worth about $49,000. Quadrant Capital Group LLC increased its position in LHC Group by 1,045.7% in the first quarter. Quadrant Capital Group LLC now owns 527 shares of the health services provider’s stock worth $57,000 after buying an additional 481 shares in the last quarter. Finally, Meeder Asset Management Inc. purchased a new stake in LHC Group in the first quarter worth about $68,000. 92.98% of the stock is currently owned by institutional investors.

In other LHC Group news, CEO Keith G. Myers sold 11,558 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $108.83, for a total value of $1,257,857.14. Following the transaction, the chief executive officer now owns 96,315 shares of the company’s stock, valued at $10,481,961.45. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Joshua L. Proffitt sold 11,003 shares of the stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $107.36, for a total value of $1,181,282.08. Following the completion of the transaction, the executive vice president now directly owns 66,980 shares in the company, valued at approximately $7,190,972.80. The disclosure for this sale can be found here. In the last three months, insiders sold 117,876 shares of company stock worth $12,762,540. 6.80% of the stock is owned by corporate insiders.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.

See Also: What is range trading?

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.